New medical advances could revolutionise the ability to treat undetected tuberculosis (TB) thanks to an international team of scientists led by the University of St Andrews.
Scientists at the School of Medicine are leading the medical monitoring of a new clinical trial to treat tuberculosis more quickly.
the first ever Molecular bacterial load assay (MBLA) stakeholders conference was held at the University of St Andrews, 11th – 13th June 2018.
Experts from around the world are gathered in St Andrews to learn how to dramatically cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives.
Dr. Wilber Sabiiti recently presented a paper at the Keystone Symposia on Translation of tuberculosis research into policy and practice.
Dr. Wilber Sabiiti recently presented some of his work at the UARC-TLD.
Dr Wilber Sabiiti has recently given a series of talks and training in different African countries showcasing the advantages of the molecular bacterial load assay (MBLA) and TWENDE work on developing model for rapid uptake of health research innovations into policy and practice.
Congratulations go to Professor Stephen Gillespie who has been elected to The Royal Society of Edinburgh.
Professor Stephen Gillespie recently attended the British Thoracic Winter Conference in London and presented two papers.
Researchers at the School of Medicine are one step closer to finding a shorter, more effective treatment for TB, according to a new paper published by The Lancet Infectious Diseases.
- Page 1 of 2